Clinical Trials Logo

Filter by:
NCT ID: NCT06218316 Enrolling by invitation - Clinical trials for Spastic Diplegic Cerebral Palsy

Repetitive Transcranial Magnetic Stimulation Versus Botulinum Injection on Spasticity on Children With Diplegic Cerebral Palsy

Start date: October 15, 2023
Phase: N/A
Study type: Interventional

This trial will enroll 75 children with spastic diplegic cerebral palsy both matched in age, sex, degree of disability and cognitive functions with the same exclusion criteria undergoing the same physical therapy. All enrolled children will undergo routine physical therapy program and will be divided into three groups (n = 25 per group) according treatment methods. Group A: children will be given local injections of botulinum toxin type ,Group B: children will be given repetitive transcranial magnetic stimulation on the affected side; Group C: children will be given local injections of botulinum toxin type A combined with repetitive transcranial magnetic stimulation , the three groups will take physical therapy (PT) of 45 minutes duration 4 days a week for 3 months .The grade of spasticity will be assessed by using Modified Ashworth scale and M/H ratio by using EMG. The grade of motor function will assessed by using Gross Motor Function Classification System (GMFCS).

NCT ID: NCT06216275 Enrolling by invitation - Dementia Clinical Trials

Enhancing Calm in Arab Elderly With Dementia

sn/dm
Start date: January 5, 2024
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to evaluate the effectiveness of integrating Snoezelen methods with aromatherapy and personal items in reducing agitation in Arab elderly individuals with dementia. The main questions it aims to answer are: Does the combination of Snoezelen methods, aromatherapy, and the use of personal items significantly reduce agitation in elderly Arab patients with dementia compared to standard care practices? How do patients and caregivers perceive the impact of this integrated approach on the overall well-being and quality of life of the patients? Participants in this study will: Engage in sessions utilizing Snoezelen methods, a multi-sensory environment designed to deliver stimuli to various senses. Receive aromatherapy treatments with selected scents known for their calming properties. Be provided with personal items that are familiar and meaningful to them, to create a sense of comfort and security.

NCT ID: NCT06198647 Enrolling by invitation - Low Back Pain Clinical Trials

Manual Therapy for Pregnancy Related Back Pain

Start date: January 15, 2024
Phase: N/A
Study type: Interventional

More than 50% of women experience pain in the lumbopelvic area during pregnancy. The prevalence of pain increases with the duration of pregnancy. Trunk muscles are needed to sustain low levels of activity for an extended duration. Preventing muscles from fatiguing is very important. Manual therapy techniques can minimize loading of the spine while improving muscular endurance and preventing fatigue. Moreover, inhibition of the trigger points of the spinal musculature is an important factor to consider.

NCT ID: NCT06197841 Enrolling by invitation - Clinical trials for Role of Neurofilment in Diagnosis of Multiple Sclerosis

Neurofilament Light Chain as Diagnostic and Prognostic Marker in naïve Multiple Sclerosis Patients

NFLMS
Start date: December 1, 2023
Phase:
Study type: Observational

Neurofilament protein detected in the serum appears to be a good marker for the extent of active neurodegeneration. Chitinase may also be a good marker reflecting the degree of astrocyte activation, or damage in active lesions (Paul et al, 2018).These markers have some clinical value for diagnosis and monitoring of disease activity. NfL can be objectively measured and quantified, it is highly sensitive to neurodegenerative processes and its concentration changes as the disease worsens or improves (Disanto et al., 2017). Numerous studies have shown that NfL levels increase during MS relapses and correlate with MRI lesion development (Disanto et al., 2016, 2017; Novakova et al., 2017), disease activity, (Thebault et al., 2020). Cognitive impairment is common in the early stages of multiple sclerosis, mainly affecting attention, working memory, and information processing speed, but also memory, inhibition, and conceptualisation. Poor performance is common but remains subtle and does not significantly affect the quality of life at this stage. However, many studies shows that these deficits reflect the destruction both within and outside lesions, and that they may therefore be considered as a severity marker in the early stages of multiple sclerosis. (Lengenfelder et al., 2005). The aim of the work is to detect the role of serum NFL and chitinase as biomarkers in the diagnosis and prognosis of newly diagnosed multiple sclerosis patients, and to estimate the incidence of cognitive impairment and their relationship with the NFL in newly diagnosed MS patients.

NCT ID: NCT06186674 Enrolling by invitation - Low Back Pain Clinical Trials

Prediction of Back Disability in Adults With Low Back Pain

Start date: December 12, 2023
Phase:
Study type: Observational

Low back pain (LBP) is one of the most enormous and challenging disorders. LBP represents a leading cause of disability worldwide. A number of variables (clinical, functional and mechanical) may predispose to back disability. Clinical variables such as pain may affect the patient ability to move and also may result in muscle spasm that led to more pain and movement restriction. Further, functional capabilities may affect the patient and when reduced may lead to disability. Moreover, biomechanical factors such as abnormal posture creates abnormal stress and strain in many spinal structures which are considered predisposing factors for pain and disability. There is a gab of evidence to examine the relationships between those variables and to predict disability in patients with chronic nonspecific low back pain using various variables.

NCT ID: NCT06147739 Enrolling by invitation - Clinical trials for Anterior Openbite Malocclusion

Evaluation Treatment Outcomes of Anterior Open Bite Treated by Temporary Anchorage Devices

Start date: August 11, 2021
Phase: N/A
Study type: Interventional

The present study will be performed to Evaluate the treatment outcome of anterior open bite by temporary anchorage device on buccal and palatal mini screws

NCT ID: NCT06146959 Enrolling by invitation - Physical Disability Clinical Trials

Corrective Calcaneal Kinesiology Tape in Adolescents With Pronated Foot

Start date: July 1, 2023
Phase: N/A
Study type: Interventional

The aim of this study is to find the effect of a program of corrective kinesiotaping on pain intensity, foot function, and the sonographic picture of plantar fascia in adolescents with pronated feet.This study hypothesizes that there will be a statistically significant effect of a program of application of the corrective technique of kinesiotaping on plantar heel pain, foot function, and the sonographic picture of plantar fascia in a sample of Egyptian adolescents suffering from pronated feet.

NCT ID: NCT06134570 Enrolling by invitation - Breast Cancer Clinical Trials

ALDH1A1 Expression in Invasive Mammary Carcinoma

Start date: October 1, 2023
Phase:
Study type: Observational

ALDH1A1 isozyme oxidizes Retinaldehyde to retinoic acid, which regulates the expression of the genes involved in tumor-initiating stem-like cells, thereby initiating tumor growth and resistance to drugs. Much emphasis has been focused on ALDH1A1 as a CSC marker. High expression of ALDH1A1 has been reported as a poor prognostic marker in several tumor types and is associated with poor patient outcomes .

NCT ID: NCT06112197 Enrolling by invitation - Insulin Resistance Clinical Trials

Study of Visceral Fat in type2diabetic Patients and Its Relation to Microvascular Complications

Start date: January 5, 2024
Phase:
Study type: Observational

Study the correlation between METS IR and visceral fat in type 2 diabetes and its relation to microvascular complication

NCT ID: NCT06107465 Enrolling by invitation - Pulmonary Edema Clinical Trials

High Versus Low Dose Nitroglycerin in Acute Pulmonary Edema

Start date: November 10, 2023
Phase: Phase 2/Phase 3
Study type: Interventional

The goal of this randomized controlled trial is evaluate the out come of: - Low dose (< 100 mic/min )versus - High dose (> 100 mic/min) of nitroglycerin in management of patients with acute pulmonary edema presented to Emergency Department of Alexandria University Hospitals. The main questions it aims to answer is: - Time of resolution of high blood pressure, hypoxia, tacchypnea - Need for invasive mechanical ventilation, ICU admission